Abstract
There is a global perception that psychotropic utilization in children and adolescents is increasing in the US. We present prevalent estimates for all psychotropics prescribed in the US (using commercial claims from Medicare and Medicaid) to children and adolescents in 2004 (total population N = 6,808,453) and in 2014 (total population N = 11,082.260). Further we evaluated if there has been a statistically significant change in prevalence during this time period. Analyses were stratified for the 6 major drug classes, all individuals' psychotropics (87 drugs), age and sex. The prevalence of psychotropic drug prescription was 8.55% in 2004 and 9.00% in 2014 (age stratified in 2004 and 2014 toddlers: 3.08 and 2.63%, children: 8.74 and 8.73%, adolescents: 10.89% and 12.11). The prevalence for each drug class in 2004 and 2014 was: stimulants/other ADHD drugs 5.0 and 5.8%; antidepressants 2.8 and 2.7%; anxiolytic-hypnotic-sedative 2.2 and 2.3%; mood stabilizers 0.1 and 0.1%; antipsychotics 1.3 and 1.1%; and for drugs treating drug dependence 0.02 and 0.02%. The perception that psychotropic utilization in children and adolescents is increasing in the US, derived from the 2 to 3 fold increase seen from the mid 80's to the mid 90's is n...Continue Reading
References
Jan 1, 1997·Journal of Child and Adolescent Psychopharmacology·D J Safer
Jan 9, 2003·Archives of Pediatrics & Adolescent Medicine·Julie Magno ZitoMark A Riddle
Jan 30, 2004·Diabetes Care·UNKNOWN American Diabetes AssociationUNKNOWN North American Association for the Study of Obesity
Mar 15, 2006·Ambulatory Pediatrics : the Official Journal of the Ambulatory Pediatric Association·William O CooperWayne A Ray
Apr 10, 2007·Mayo Clinic Proceedings·Timothy W LineberryPaul A Decker
Oct 4, 2008·Psychiatric Services : a Journal of the American Psychiatric Association·Robert Constantine, Rajiv Tandon
Mar 19, 2009·Journal of Autism and Developmental Disorders·Rebecca E RosenbergWalter E Kaufmann
Aug 7, 2009·Psychological Medicine·I TarriconeD Berardi
Oct 29, 2009·JAMA : the Journal of the American Medical Association·Christoph U CorrellAnil K Malhotra
Oct 18, 2011·Pediatrics·UNKNOWN Subcommittee on Attention-Deficit/Hyperactivity DisorderSusanna Visser
Feb 14, 2012·Academic Pediatrics·Craig F GarfieldG Caleb Alexander
Jan 16, 2013·Psychiatric Services : a Journal of the American Psychiatric Association·Rachel KornfieldG Caleb Alexander
Nov 14, 2013·JAMA : the Journal of the American Medical Association·Bridget M Kuehn
Nov 29, 2013·JAMA Psychiatry·Mark OlfsonChristoph U Correll
Jun 20, 2014·BMJ : British Medical Journal·Christine Y LuStephen B Soumerai
Jun 24, 2014·Journal of the American Academy of Child and Adolescent Psychiatry·Boris LorbergTimothy Wilens
Oct 30, 2014·The New England Journal of Medicine·Richard A Friedman
Mar 4, 2015·JAMA : the Journal of the American Medical Association·Ian SchmidJulie M Zito
Apr 22, 2015·Journal of Child and Adolescent Psychopharmacology·W David LohrPatricia Gail Williams
Jul 2, 2015·JAMA Psychiatry·Mark OlfsonMichael Schoenbaum
Sep 10, 2015·The New England Journal of Medicine·Katherine J RansohoffKavita Y Sarin
Jan 30, 2016·BMC Psychiatry·Ingeborg HartzMarte Handal
Dec 13, 2016·Pediatrics·Ramin MojtabaiBeth Han
Citations
Apr 11, 2019·Psychiatric Services : a Journal of the American Psychiatric Association·Elizabeth Hisle-GormanGregory H Gorman
Aug 6, 2019·Health Affairs·Elizabeth Hisle-GormanGregory H Gorman
Jan 25, 2020·Journal of Child and Adolescent Psychopharmacology·Beate OerbeckLars Lien
Mar 21, 2020·The American Journal of Gastroenterology·Craig C ReedEvan S Dellon
Nov 24, 2020·Therapeutic Advances in Psychopharmacology·David Cohen, Alexander Recalt
Apr 13, 2021·JAMA Network Open·Luise KazdaAlexandra Barratt
Apr 29, 2021·Journal of Child and Adolescent Psychopharmacology·Lisa HutchisonYehuda Lerea
Jul 10, 2021·Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie·Clara BothAlexander Häge
Sep 3, 2021·Psychiatric Services : a Journal of the American Psychiatric Association·W David LohrDeborah Winders Davis
Jul 7, 2019·Pediatrics·Adam OverbergBlake Froberg